To this end, using the well-established MMTV-erbB-2 mouse model in our current study, we found that buformin inhibits cell proliferation, cell cycle, and CSC self-renewal properties in erbB-2-overexpressing breast cancer cells. Here, ERBB2 is linked to breast carcinoma.